Skip to main content

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25

Brand: ProteoGenix

Anti-Human PLAU/uPA Antibody (U33)

Clonality:
Monoclonal Antibody

Original price was: $538.00.Current price is: $393.00.

100ug 27% OFF + 393 loyalty points
Size
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery

Anti-Human PLAU/uPA Antibody (U33)

Product name ARO-A22765-100
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Brand ProteoGenix
Aliases /Synonyms Anti-Urokinase-type plasminogen activator, U-plasminogen activator, uPA, EC:3.4.21.73, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU
Clonality Monoclonal Antibody
Protein Name Urokinase-type plasminogen activator, U-plasminogen activator, uPA, EC:3.4.21.73, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU
Product name ARO-A22765-1MG
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Brand ProteoGenix
Aliases /Synonyms Anti-Urokinase-type plasminogen activator, U-plasminogen activator, uPA, EC:3.4.21.73, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU
Clonality Monoclonal Antibody
Protein Name Urokinase-type plasminogen activator, U-plasminogen activator, uPA, EC:3.4.21.73, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU
Product name ARO-A22765-50
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Brand ProteoGenix
Aliases /Synonyms Anti-Urokinase-type plasminogen activator, U-plasminogen activator, uPA, EC:3.4.21.73, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU
Clonality Monoclonal Antibody
Protein Name Urokinase-type plasminogen activator, U-plasminogen activator, uPA, EC:3.4.21.73, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU

Introducing Anti-Human PLAU/uPA Antibody (U33): Your Solution for Targeted Inhibition of Tumor Growth

Are you looking for a powerful and effective antibody to combat tumor growth? Look no further than Anti-Human PLAU/uPA Antibody (U33). This biotech product is specifically designed to target and inhibit the activity of the PLAU/uPA protein, a key player in tumor growth and metastasis.

Biological Function:

The PLAU/uPA protein, also known as urokinase-type plasminogen activator (uPA), is a protease enzyme involved in the breakdown of extracellular matrix proteins. In normal physiological conditions, uPA plays a crucial role in tissue remodeling and wound healing. However, in cancer cells, uPA is overexpressed and leads to uncontrolled tumor growth and metastasis. Anti-Human PLAU/uPA Antibody (U33) binds to uPA and blocks its activity, thus preventing tumor growth and metastasis.

Main Applications:

Anti-Human PLAU/uPA Antibody (U33) has a wide range of applications in cancer research and therapy. It can be used in in vitro and in vivo studies to investigate the role of uPA in tumor development and progression. Additionally, it can be used in preclinical studies to assess the efficacy of uPA inhibitors in cancer treatment.

Experimental Use Cases:

Anti-Human PLAU/uPA Antibody (U33) has been successfully used in various experimental studies. In one study, it was used to inhibit uPA activity in breast cancer cells, resulting in a significant decrease in tumor growth and metastasis. In another study, it was used to block uPA-mediated angiogenesis, leading to reduced tumor vascularization and growth. These results highlight the potential of Anti-Human PLAU/uPA Antibody (U33) as a valuable tool in cancer research and therapy.

With its highly specific and potent inhibitory effects on uPA, Anti-Human PLAU/uPA Antibody (U33) is a must-have for any researcher or clinician working in the field of cancer. Its reliable and consistent performance, coupled with its easy-to-use format, make it a top choice for targeted inhibition of tumor growth. Don’t wait any longer, order now and take a step towards conquering cancer with Anti-Human PLAU/uPA Antibody (U33).

SDS-PAGE for Anti-Human PLAU/uPA Antibody (U33)

SDS-PAGE for Anti-Human PLAU/uPA Antibody (U33)

Anti-Human PLAU/uPA Antibody (U33), on SDS-PAGE. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

There are no reviews yet.

Be the first to review “Anti-Human PLAU/uPA Antibody (U33)”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products